May 8, 2020

Pricing Patient Lives

Pricing Patient Lives
The player is loading ...
Patients Rising Podcast

Health economist Dr. Paul C. Langley explains the faults in ICER’s price calculations. Dr. Bob discusses his antibody test for COVID-19, and Kate speaks with a mother whose son passed away due to insulin rationing. 

Guest:

Paul C. Langley, Ph.D. Health economist and adjunct professor in the College of Pharmacy, University of Minnesota 

Dr. Paul C. Langley is a health economist with an extensive background in drug evaluation for pharmacy and therapeutics companies. In the early 1990’s, Dr. Langley evaluated the economics for the introduction of new pharmaceutical products. In Australia, he worked, until 1994, to analyze cost-effectiveness cases brought forward by pharmaceutical companies introducing new products.

After moving to America, Dr. Langley produced numerous research projects regarding evaluation techniques for the introduction of new pharmaceutical and therapeutic products to the United States. In 1997, he also established the Center for Pharmaceutical Economics at the University of Colorado. 

From 1999 to 2005, Dr. Langley used his global experience and perspective in his role as International Manager, Health Economics, at 3M Pharmaceuticals. 

Dr. Langley’s research papers largely focus on issues of population health. His recent publications have analyzed how ICER’s cost-effectiveness claims in the U.S. do not meet scientific standards. 

Currently, Dr. Langley is the director of Maimon Research LLC, an Arizona-based health economics consulting and research company. He also works as an adjunct professor at the University of Minnesota’s College of Pharmacy. Dr. Langley is currently an Advisory Board Member and Research Director for the Institute of Patient Access. 

Dr. Langley earned his B.S. in economics from the University of Hull in the U.K., his M.A. from Carleton University, and his Ph.D. from Queen’s University in Canada. 

Hosts:

Terry Wilcox, Executive Director, Patients Rising

Dr. Robert Goldberg, “Dr. Bob”, Co-Founder and Vice President of the Center for Medicine in the Public Interest.

Kate Pecora, Field Correspondent 

Links:

Maimon Research LLC

Patients Rising Concierge 

Need help?

The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands. Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.org

Have a question or comment about the show, want to suggest a show topic or share your story as a patient correspondent?

Drop us a line: podcast@patientsrising.org

The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.

Paul C. Langley, Ph.D.

Adjunct Professor in the College of Pharmacy, University of Minnesota

Dr. Paul Langley, a Health economist and adjunct professor in the College of Pharmacy at the University of Minnesota, has an extensive background in drug evaluation for pharmacy and therapeutics companies. Dr. Langley is also currently the director of Maimon Research LLC, an Arizona-based health economics consulting and research company, and is an Advisory Board Member and Research Director for the Institute of Patient Access.

Nicole Smith-Holt

Advocate for affordable insulin

Charity Ambassador for T1International

Grace

Patient Correspondent, NY-10

Christina Consavlos

Patient Correspondent, CA-53